Breaking News Instant updates and real-time market news.

INVA

Innoviva

$15.90

(0.00%)

09:32
04/19/18
04/19
09:32
04/19/18
09:32

Innoviva initiated with a Buy at Berenberg

Berenberg analyst Patrick Trucchio initiated Innoviva with a Buy and $22 price target.

INVA Innoviva
$15.90

(0.00%)

05/01/17
COWN
05/01/17
NO CHANGE
Target $16
COWN
Outperform
Innoviva weakness a buying opportunity, says Cowen
Cowen analyst Tyler Van Buren said the recent earnings miss at Innoviva was largely non-fundamental and impacted by pressures that he expects will reverse in Q2. He said prescriptions look great and he views the weakness in Innoviva shares as a buying opportunity. Van Buren reiterated his Outperform rating and $16 price target on Innoviva shares.
11/20/17
DBAB
11/20/17
INITIATION
Target $13
DBAB
Hold
Innoviva initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Esther Rajavelu started Innoviva (INVA) with a Hold rating and $13 price target. The analyst is concerned about revenue concentration and sees no near-term growth opportunities outside of the GlaxoSmithKline (GSK) partnership.
11/20/17
11/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Innoviva (INVA) initiated with a Hold at Deutsche Bank. 2. National Vision (EYE) was initiated with an Overweight at Morgan Stanley, an Outperform at Wells Fargo, a Buy at Jefferies and Citi, as well as a Neutral at Goldman Sachs, UBS, and BofA/Merrill. 3. Ablynx (ABLX) was initiated with an Overweight at JPMorgan, an Outperform at Baird, and a Buy at Ladenburg. 4. Blue Apron (APRN) initiated with a Sector Weight at KeyBanc. 5. BP Midstream (BPMP) was initiated with an Overweight at JPMorgan, a Buy at UBS and Citi, an Equal Weight at Morgan Stanley and Barclays, as well as a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/18/17
MSCO
12/18/17
NO CHANGE
MSCO
Morgan Stanley sees opportunities in biotech amid 'limited' investor conviction
With clinical catalysts in large-cap Biotechnology limited to only five key Phase III readouts - three of which are from Alexion (ALXN) - investors are describing their 2018 picks in the space as the "least worst" of the group, according to Morgan Stanley analyst Matthew Harrison. However, he believes this lack of conviction creates real opportunity for outsized moves in 2018, with Amgen (AMGN) identified by Harrison as the biggest potential beneficiary of M&A given "its likely newfound access" to about $39B in offshore cash. Other biotech names the analyst highlights on the up side include Biogen (BIIB), BioMarin (BMRN), Biohaven (BHVN) and Sarepta (SRPT). Meanwhile, Harrison highlights his concerns about potential downside for BioVerativ (BIVV) and Innoviva (INVA), on both of which he keeps Underweight ratings.

TODAY'S FREE FLY STORIES

RMBL

RumbleON

$4.88

0.16 (3.39%)

16:10
05/25/18
05/25
16:10
05/25/18
16:10
Syndicate
Breaking Syndicate news story on RumbleON »

RumbleON files $20M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAVS

Ageagle Aerial Systems

$2.25

0.04 (1.81%)

16:10
05/25/18
05/25
16:10
05/25/18
16:10
Syndicate
Breaking Syndicate news story on Ageagle Aerial Systems »

Ageagle Aerial Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCI

Appliance Recycling

$0.82

(0.00%)

16:08
05/25/18
05/25
16:08
05/25/18
16:08
Hot Stocks
Appliance Recycling receives noncompliance notice from NASDAQ »

Appliance Recycling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIT

CIT Group

$51.62

-1.13 (-2.14%)

16:06
05/25/18
05/25
16:06
05/25/18
16:06
Hot Stocks
CIT Group names Marisa Harney chief risk officer »

CIT Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRVG

Trivago

$4.81

(0.00%)

16:04
05/25/18
05/25
16:04
05/25/18
16:04
Hot Stocks
Breaking Hot Stocks news story on Trivago »

Par Investment Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGLN

Magellan Health

$90.05

1.1 (1.24%)

15:56
05/25/18
05/25
15:56
05/25/18
15:56
Hot Stocks
Magellan Health boosts stock repurchase authorization to $400M »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

LPI

Laredo Petroleum

$8.60

-0.765 (-8.17%)

15:50
05/25/18
05/25
15:50
05/25/18
15:50
Options
Notable put spread in Laredo Petroleum on a rough week for shares »

Notable put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$14.57

-0.025 (-0.17%)

15:42
05/25/18
05/25
15:42
05/25/18
15:42
Periodicals
GE lighting business, pursued by multiple suitors, could fetch $1B, FBN says »

Charles Gasparino of Fox…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$37.03

0.15 (0.41%)

15:40
05/25/18
05/25
15:40
05/25/18
15:40
Options
AstraZeneca call buyer opens position 4% above spot »

AstraZeneca call buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

HEDJ

WisdomTree Europe Hedged Equity Fund

$66.46

-0.24 (-0.36%)

15:30
05/25/18
05/25
15:30
05/25/18
15:30
Options
Wisdom Tree Europe Hedged Equity Fund attracts put buying »

Wisdom Tree Europe Hedged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATUS

Altice USA

$18.43

-0.12 (-0.65%)

15:29
05/25/18
05/25
15:29
05/25/18
15:29
Conference/Events
Altice USA management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

CLX

Clorox

$122.59

2.89 (2.41%)

15:25
05/25/18
05/25
15:25
05/25/18
15:25
Options
Clorox call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

QCOM

Qualcomm

$59.67

0.57 (0.96%)

, NXPI

NXP Semiconductors

$116.47

5.03 (4.51%)

15:22
05/25/18
05/25
15:22
05/25/18
15:22
Periodicals
Dealreporter: Qualcomm given ok to resume NXP talks with China, Bloomberg says »

Bloomberg cites…

QCOM

Qualcomm

$59.67

0.57 (0.96%)

NXPI

NXP Semiconductors

$116.47

5.03 (4.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OA

Orbital ATK

$133.80

0.06 (0.04%)

15:20
05/25/18
05/25
15:20
05/25/18
15:20
Hot Stocks
Orbital ATK reports options awarded for two more weather satellites for NOAA »

Orbital ATK announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
05/25/18
05/25
15:17
05/25/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADRNY

Ahold Delhaize

$0.00

(0.00%)

15:16
05/25/18
05/25
15:16
05/25/18
15:16
Conference/Events
Ahold Delhaize management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
05/25/18
05/25
15:16
05/25/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKY

Skyline

$30.20

-0.31 (-1.02%)

15:10
05/25/18
05/25
15:10
05/25/18
15:10
Conference/Events
Skyline to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBOE

Cboe Global Markets

$102.62

-0.13 (-0.13%)

15:05
05/25/18
05/25
15:05
05/25/18
15:05
Options
CBOE Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOXO

Loxo Oncology

$167.50

-0.06 (-0.04%)

14:57
05/25/18
05/25
14:57
05/25/18
14:57
Conference/Events
Loxo Oncology to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

AMSC

AMSC

$6.45

-0.2 (-3.01%)

14:49
05/25/18
05/25
14:49
05/25/18
14:49
Options
AMSC options imply 9.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$277.67

-0.18 (-0.06%)

14:44
05/25/18
05/25
14:44
05/25/18
14:44
Periodicals
Tesla flies in new equipment to speed battery output for Model 3, Reuters says »

Tesla is making the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$187.70

0.65 (0.35%)

14:40
05/25/18
05/25
14:40
05/25/18
14:40
Conference/Events
Bluebird Bio to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 15

    Jun

KKR

KKR

$22.46

-0.04 (-0.18%)

14:40
05/25/18
05/25
14:40
05/25/18
14:40
Options
KKR options active and the bullish flow includes a large call spread »

KKR options active and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

SPY

SPDR S&P 500 ETF Trust

$271.97

-0.9 (-0.33%)

14:30
05/25/18
05/25
14:30
05/25/18
14:30
Options
Aggressive short-term spread opened in SPYders »

Aggressive short-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.